Examination of Postdural Puncture Headache Frequency, Predisposing Factors and Treatment (PDPH)

April 26, 2024 updated by: Mustafa Soner Ozcan

Examination of Postdural Puncture Headache Frequency, Predisposing Factors and Treatment Applied in Patients Undergoing Spinal Anesthesia

Post-dural puncture headache (PDPH) is one of the most important complications of neuraxial blocks and lumbar interventions for cerebrospinal fluid (CSF) examination. It occurs due to tear in the dura mater and loss of cerebrospinal fluid (CSF) after intrathecal or epidural interventions.The incidence of PDPH depends on the thickness of the needle used and the type of tip. Headaches are more common with thick needles than with thin needles.In our study, postdural puncture headache in patients whose surgery was planned and spinal anesthesia was applied at Süleyman Demirel University faculty of medicine;frequency, predisposing factors, treatment intended to examine.

Study Overview

Status

Completed

Detailed Description

Different anesthesia techniques are applied to patients undergoing surgery. These are general anesthesia and regional (Spinal, Epidural, peripheral nerve blocks, etc.) anesthesia applications. Today, regional anesthesia is the most frequently preferred anesthesia method by anesthesiologists due to its low side effects. Spinal anesthesia is the temporary stopping of nerve conduction with a local anesthetic solution injected into the cerebrospinal fluid. It is one of the most commonly used regional anesthesia techniques today.Important advantages of regional anesthesia include the patient's continued spontaneous breathing, preservation of oropharyngeal reflexes, continuation of analgesia in the postoperative period, early mobilization, and short hospital stay.Post-dural puncture headache (PDPH) is one of the most important complications of neuraxial blocks and lumbar interventions for cerebrospinal fluid (CSF) examination. The incidence of PDPH is significantly higher in young people than in the elderly, in women compared to men, and in pregnant women compared to the normal population.In our study, spinal anesthesia cases will be examined. Patients with headache will be identified. Patients' demographic data (age, height, body weight, gender, comorbidities), ASA (American Society of Anesthesiologists) score, operation type, presence of headache etiology, needle type and diameter used, number of interventions and procedures. level, amount of local anesthetic given, adjuvant drugs added, experience of the practitioner, amount of fluid given, date and time of headache onset, treatment and procedure complications will be monitored and recorded in the form.

Study Type

Observational

Enrollment (Actual)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Isparta, Turkey, 32200
        • Suleyman Demirel University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

18 years and over

Description

Inclusion Criteria:

18 years and over ASA risk score I - II - III Patients with body mass index (BMI <40 kg/m²) Patients undergoing spinal anesthesia

Exclusion Criteria:

ASA IV, V, concomitant severe cardiac, respiratory, hepatic, renal disease Patients who do not want spinal anesthesia Those who are allergic to the medications used Those with localized infection at the injection site Those who have coagulopathy and use anticoagulant drugs Those with a history of chronic pain (migraine, sinusitis, etc.) Those with alcohol and opioid addiction Psychiatric diseases and patients with communication difficulties Those with vertebra or chest wall abnormalities Those with obesity (BMI > 40 kg/m²)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
POSTDURAL PUNCTURE HEADHECHE
We don't use drug

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postdural puncture headache frequency
Time Frame: 6 months
After spinal anesthesia, patients will be monitored for postdural puncture headaches, and their frequency will be determined.
6 months
postdural puncture headache treatments
Time Frame: 6 months
Postdural puncture headache treatments decided to be applied will be noted and the results will be evaluated.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relationship between postdural puncture headache and predisposing factors
Time Frame: 6 months
Predisposing factors that play a role in the development of patients' headache will be evaluated separately with the data to be obtained (e.g. age, needle size, hydration, previous medical history, comorbities, practitioner's experience etc.)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mustafa Soner Mustafa Soner, Suleyman Demirel University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Actual)

March 1, 2024

Study Completion (Actual)

March 31, 2024

Study Registration Dates

First Submitted

April 16, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

May 1, 2024

Study Record Updates

Last Update Posted (Actual)

May 1, 2024

Last Update Submitted That Met QC Criteria

April 26, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postdural Puncture Headache

Subscribe